Zongatinib (Zongatinib) price and reference cost in 2025

Zongertinib (Zongertinib) is a targeted drug mainly used to treat cancers related to specific gene mutations. The drug is already on the market in China, but due to its short time on the market, some hospitals and pharmacies have not yet fully supplied it. It may be difficult for patients to purchase the drug directly. Therefore, when domestic patients currently obtain Zonatinib, they need to consult the hospital pharmacy in advance or make an appointment through formal channels.

From a price point of view, the overseas version of Zovitinib is more expensive. Taking the U.S. market as an example, the price of each box of original medicine is about 20more than 10,000 yuan. The specific cost may vary due to specifications and exchange rate changes. This price level reflects the innovation and research and development costs of the drug, and also reflects its value as a targeted drug in the treatment of drug-resistant cancer.

At present, there are no generic drugs of Zovitinib in China. Therefore, if patients want to use the drug, they can only rely on the original drug or import it through formal overseas channels. Due to the lack of generic versions, drug prices are relatively high, and patients need to be fully prepared in terms of finances and affordability. At the same time, when issuing prescriptions, doctors will conduct a comprehensive assessment based on the patient's condition, medication history and economic conditions to formulate a reasonable medication plan.

Overall, Zongertinib, as a newly launched targeted drug, has high clinical value, but its price is high and its channels are limited. When purchasing and using drugs, patients should obtain them through regular hospitals and pharmacies, and use them under the guidance of professional doctors to ensure efficacy and safety. At the same time, attention should be paid to the dynamic changes in domestic drug listings and medical insurance policies. In the future, there may be more convenience and cost support for drug purchase.

Reference materials:https://www.drugs.com/